Last reviewed · How we verify
NCT06679452
Emotion, Aging, and Forgiveness: Protocol for a Feasibility of Randomized Controlled Trial
NA trial testing Emotion-Focused Therapy in Emotion-Focused Therapy in 70 participants. Not yet recruiting.
1 December 2025
Quick facts
| Lead sponsor | University of Maia |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 April 2025 |
| Primary completion | 1 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Emotion-Focused Therapy
Conditions studied
- Emotion-Focused Therapy — all drugs for Emotion-Focused Therapy →
- Aging — all drugs for Aging →
- Forgiveness — all drugs for Forgiveness →
Sponsor
University of Maia
Who can join
65 and older, any sex, with Emotion-Focused Therapy or Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Over recent decades, Emotion-Focused Therapy, aging, and forgiveness have garnered significant attention in the field of psychology. However, there is a lack of studies on Emotion-Focused Therapy and forgiveness specifically tailored for older adults. This article describes a protocol to assess the feasibility and acceptability of a Randomized Controlled Trial of Emotion-Focused Therapy for the resolution of emotional injury in individuals over the age of 65 in the context of interpersonal offenses. The study is structured as a two-arm, parallel-group randomized trial with a waiting list control. We propose recruiting a sample of 70 participants, randomly assigned to either an immediate intervention group, which will receive Emotion-Focused Therapy over twelve weekly sessions, or a control group that will receive the same therapy after a twelve-week waiting period. Data will be collected in the beginning, middle, and at the end of therapy, and in two planned follow-ups (three and six months after therapy). Once this protocol is implemented, if the therapy proves to be feasible, acceptable, and shows promising results, the findings will inform a large-scale randomized clinical trial to advance the understanding of psychotherapy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Emotion-focused therapy and forgiveness in the older population: Protocol for a feasibility randomized controlled trial.
d'Almeida BC, Cunha C. · · 2026 · PMID 42127130 · DOI 10.1371/journal.pone.0345792
Verify or expand the search:
- PubMed search for NCT06679452
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Emotion-Focused Therapy
Trials testing the same drug.
- NCT04690946 — Comparing Effect and Change Processes in Cognitive Behavioral Therapy and Emotion-Focused Therapy for Depression · NA · completed
Other University of Maia trials
Trials by the same sponsor.
- NCT07343518 — Effects of Sulforaphane Supplementation on Athletic Performance · NA · not yet recruiting
- NCT07321496 — The Most Demanding Match Periods: Should GPS Data be Normalized · active not recruiting
- NCT07135830 — Ashwagandha (Withania Somnifera) and Its Effects on Recovery Perceived and Muscle Strength in Male Handball Players · NA · not yet recruiting
- NCT06921005 — Can Lower-body Occlusion Influence Sports Recovery? · NA · not yet recruiting
- NCT06815640 — Effects of Intermittent Pneumatic Compression on Recovery of Cyclists · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06679452 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Maia
- Last refreshed: 13 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06679452.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing